This test is designed to detect clonal cytoplasmic immunoglobulin M (cIgM) expression in precursor B-cell populations, primarily in cases of Pre-B Acute Lymphoblastic Leukemia (ALL). Detection of clonal restriction of cIgM can serve as a prognostic marker, helping to evaluate disease characteristics and guide therapeutic decisions.